GSK3B and hepatocellular carcinoma: FBXO17 expression was found to be upregulated in hepatocellular carcinoma, and it regulated β-catenin, GSK3β, cyclin D1 and c-Myc function, suggesting that the entire Wnt axis was regulated by FBXO17 24.